"Additional Effects of Sternocleidomastoid Release Along With Suboccipital Muscle Release in Management of Cervicogenic Headache'
Launched by FOUNDATION UNIVERSITY ISLAMABAD · Dec 9, 2024
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a specific type of headache called cervicogenic headache, which is caused by issues in the neck. The study aims to find out if a treatment that involves relaxing certain neck muscles can help relieve these headaches more effectively than other methods. If you experience headaches that happen at least once a month and are accompanied by neck stiffness or pain on one side, you might be eligible to participate. The trial is open to both men and women aged 18 to 45.
Participants in the study will undergo a treatment that focuses on releasing tension in the sternocleidomastoid and suboccipital muscles, which are located in the neck. This treatment is designed to help improve your headache symptoms. It’s important to note that if you have certain neck conditions, like herniated discs or previous neck surgery, you may not qualify for this study. If you're interested in learning more or think you might be a good fit, please reach out to the research team for further details.
Gender
ALL
Eligibility criteria
- • Inclusion Criteria
- * Participants will be included according to international classification of headache criteria which includes:
- • Headache with neck stiffness
- • Headache at least once a month in the last 3 months
- • Headache with at least 4 score in Numeric Pain Rating Scale(NPRS)
- • Unilateral headache with no shift of side
- • Positive flexion rotation test (Rotation restriction is greater than 10 degrees)
- • C1-C2 dysfunction
- • Headache precipitated by sustained neck movements,myofacial trigger points palpation in neck
- • Age group 18-45
- • Both male and female
- Exclusion Criteria:
- • Cervical spondylosis
- • Headache of non-cervical origin
- • Dizziness or visual disturbance
- • Cervical radiculopathy/ nerve root involvement/ disc herniation
- • Cervical instability/ fracture
- • Vertebrobasilar insufficiency
- • Thoracic outlet syndrome
- • Cervical spine surgery
- • Cervical spondylolisthesis
- • Spinal infection or tumors
- • Osteoporosis
- • meningitis
- • subarachnoid hemorrhage
About Foundation University Islamabad
Foundation University Islamabad (FUI) is a prominent educational institution dedicated to advancing research and innovation in various fields, including clinical sciences. With a commitment to excellence in education and healthcare, FUI fosters a collaborative environment that encourages multidisciplinary research initiatives. The university actively engages in clinical trials aimed at improving patient outcomes and contributing valuable insights to the medical community. Through its state-of-the-art facilities and a team of experienced professionals, Foundation University Islamabad strives to uphold the highest ethical standards in clinical research, ensuring the integrity and reliability of its findings.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rawalpindi, Punjab, Pakistan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported